Christopher J. Matheson

1.3k citations

22 papers · 977 indexed · h-index 13

Co-authors: Philip Reigan Donald S. Backos Steffanie L. Furtek Bernard T. Golding Ian R. Hardcastle Roger J. Griffin Christopher R. Coxon Céline Cano
Topics: Computational Drug Discovery Methods (4 papers)Microtubule and mitosis dynamics (4 papers)Melanoma and MAPK Pathways (4 papers)
Cited by: Oncology Molecular Biology Toxicology
Journals: Journal of Biological ChemistrySHILAP Revista de lepidopterologíaTrends in Pharmacological Sciences
Partner nations: United States United Kingdom Australia

In The Last Decade

Christopher J. Matheson

21 papers receiving 970 citations

Peers

Countries citing papers authored by Christopher J. Matheson

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Matheson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Matheson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Matheson more than expected).

Fields of papers citing papers by Christopher J. Matheson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Matheson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Matheson. The network helps show where Christopher J. Matheson may publish in the future.

Co-authorship network of co-authors of Christopher J. Matheson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Matheson. A scholar is included among the top collaborators of Christopher J. Matheson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Matheson. Christopher J. Matheson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	N-Substituted pyrrolopyrimidines and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors 2021 ·Bioorganic & Medicinal Chemistry ·(unknown),Christopher J. Matheson,(unknown),Donald S. Backos,Philip Reigan	8
2	Substituted pteridinones, pyrimidines, pyrrolopyrimidines, and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors: Pharmacophore modeling data 2021 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Christopher J. Matheson,Donald S. Backos,Philip Reigan	0
3	Evaluation of Thymidine Phosphorylase Inhibitors in Glioblastoma and Their Capacity for Temozolomide Potentiation 2021 ·ACS Chemical Neuroscience ·(unknown),Christopher J. Matheson,Debbie G. McArthur,Donald S. Backos,Philip Reigan	2
4	2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase 2020 ·RSC Medicinal Chemistry ·Christopher J. Matheson,Christopher R. Coxon,Richard Bayliss,Kathy Boxall,Benoît Carbain,Andrew M. Fry,Ian R. Hardcastle,Suzannah J. Harnor,Corine Mas-Droux,David R. Newell,Mark W. Richards,(unknown),David M. Turner,Roger J. Griffin,Bernard T. Golding,Céline Cano	14
5	Substituted oxindol-3-ylidenes as AMP-activated protein kinase (AMPK) inhibitors 2020 ·European Journal of Medicinal Chemistry ·Christopher J. Matheson,(unknown),Donald S. Backos,(unknown),Craig T. Jordan,Philip Reigan	20
6	Molecular docking of substituted pteridinones and pyrimidines to the ATP-binding site of the N-terminal domain of RSK2 and associated MM/GBSA and molecular field datasets 2020 ·SHILAP Revista de lepidopterología ·(unknown),Christopher J. Matheson,Donald S. Backos,Philip Reigan	23
7	Substituted pteridinones as p90 ribosomal S6 protein kinase (RSK) inhibitors: A structure-activity study 2020 ·Bioorganic & Medicinal Chemistry ·(unknown),Christopher J. Matheson,Donald S. Backos,Philip Reigan	10
8	Selective Targeting of RSK Isoforms in Cancer 2017 ·Trends in cancer ·(unknown),Christopher J. Matheson,Donald S. Backos,Philip Reigan	54
9	Targeting WEE1 Kinase in Cancer 2016 ·Trends in Pharmacological Sciences ·Christopher J. Matheson,Donald S. Backos,Philip Reigan	306
10	A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain 2016 ·European Journal of Pharmacology ·Boris Tabakoff,Wen-Hua Ren,Lauren A. Vanderlinden,Lawrence D. Snell,Christopher J. Matheson,Zejun Wang,(unknown),C. Thetford Smothers,John J. Woodward,Yumiko Honse,David M. Lovinger,Anthony M. Rush,William A. Sather,Daniel L. Gustafson,Paula L. Hoffman	6
11	Structure-guided design of purine-based probes for selective Nek2 inhibition 2016 ·Oncotarget ·Christopher R. Coxon,Christopher Wong,Richard Bayliss,Kathy Boxall,(unknown),Andrew M. Fry,Ian R. Hardcastle,Christopher J. Matheson,David R. Newell,(unknown),Huw D. Thomas,David M. Turner,Sharon Yeoh,Lan Z. Wang,Roger J. Griffin,Bernard T. Golding,Céline Cano	12
12	A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells 2016 ·ACS Chemical Biology ·Christopher J. Matheson,Sujatha Venkataraman,Vladimir Amani,Peter S. Harris,Donald S. Backos,Andrew M. Donson,Michael F. Wempe,Nicholas K. Foreman,Rajeev Vibhakar,Philip Reigan	48
13	Strategies and Approaches of Targeting STAT3 for Cancer Treatment 2016 ·ACS Chemical Biology ·Steffanie L. Furtek,Donald S. Backos,Christopher J. Matheson,Philip Reigan	310
14	Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors 2016 ·Molecular Cancer Therapeutics ·Weipeng Xiong,Christopher J. Matheson,Mei Xu,Donald S. Backos,Taylor Mills,(unknown),Katja Kiseljak‐Vassiliades,Philip Reigan,Margaret E. Wierman	18
15	RSK3: A regulator of pathological cardiac remodeling 2015 ·IUBMB Life ·Eliana C. Martinez,Catherine Passariello,Jinliang Li,Christopher J. Matheson,Kimberly L. Dodge‐Kafka,Philip Reigan,Michael S. Kapiloff	15
16	Trifluoroacetic Acid in 2,2,2‐Trifluoroethanol Facilitates S_NAr Reactions of Heterocycles with Arylamines 2014 ·Chemistry - A European Journal ·Benoît Carbain,Christopher R. Coxon,Honorine Lebraud,Kristopher J. Elliott,Christopher J. Matheson,(unknown),(unknown),David M. Turner,Christopher Wong,Céline Cano,Roger J. Griffin,Ian R. Hardcastle,Bernard T. Golding	31
17	Allosteric Inhibitors of the Eya2 Phosphatase Are Selective and Inhibit Eya2-mediated Cell Migration 2014 ·Journal of Biological Chemistry ·Aaron Krueger,David Drasin,Wendy Lea,Aaron Patrick,Samarjit Patnaik,Donald S. Backos,Christopher J. Matheson,Xin Hu,Elena Barnaeva,Michael Holliday,Melanie A. Blevins,Tyler P. Robin,Elan Eisenmesser,Marc Ferrer,Anton Simeonov,Noel Southall,Philip Reigan,Juan Marugán,Heide L. Ford,Rui Zhao	43
18	Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocycles 2013 ·Organic & Biomolecular Chemistry ·Honorine Lebraud,Christopher R. Coxon,(unknown),(unknown),Benoît Carbain,Christopher J. Matheson,David M. Turner,Céline Cano,Roger J. Griffin,Ian R. Hardcastle,U. Baisch,Ross W. Harrington,Bernard T. Golding	21
19	118 2-arylamino-6-ethynylpurines as Potent Irreversible Inhibitors of the Mitotic Kinase Nek2 2012 ·European Journal of Cancer ·Benoît Carbain,Richard Bayliss,K. Boxall,(unknown),Honorine Lebraud,Christopher J. Matheson,Donna Turner,(unknown),Robert Griffin	3
20	Images of Lawrence 1988 ·Medical Entomology and Zoology ·(unknown),Christopher J. Matheson	1

About Christopher J. Matheson

Christopher J. Matheson is a scholar working on Computational Theory and Mathematics, Organic Chemistry and Cell Biology, having authored 22 papers that have together received 977 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (4 papers), Microtubule and mitosis dynamics (4 papers) and Melanoma and MAPK Pathways (4 papers). The work is most often cited by research in Oncology (442 citations), Molecular Biology (647 citations) and Toxicology (31 citations). Christopher J. Matheson has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Philip Reigan, Donald S. Backos, Steffanie L. Furtek, Bernard T. Golding, Ian R. Hardcastle, Roger J. Griffin, Christopher R. Coxon, Céline Cano, David M. Turner and Sujatha Venkataraman. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Trends in Pharmacological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact